Skip to content

AI Symposium Session Summary: Is AI in clinical trials delivering measurable ROI?

Date: August 12, 2025

At the 4th Annual ACDM Symposium on Artificial Intelligence (AI) in Clinical Trials, the session “Overcoming AI Hype for Realised ROI: Taking a Problem-Centred Approach to Enterprise Transformation” confronted this challenge head-on.

Led by Jason Housley (eClinical Solutions), the discussion pulled no punches on why stubborn timelines persist despite decades of “next-gen” innovation – from blockchain to wearables to today’s AI.

Drawing on industry survey data, real-world case studies, and his “Golden Rules” for sustainable transformation, Jason shared how organisations can cut through the buzz and focus on the problems that truly matter – delivering tangible, measurable results rather than symbolic go-lives.

Read the session summary for key takeaways – pragmatic, experience-based, and laser-focused on turning AI potential into real ROI.

Click here to read

 

 


 

Explore More News

Welcome Climedo as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Climedo as a . . .

Read More

Clinical Trials for Medicines – New Notification Scheme

The MHRA have recently launched a new notification scheme, the first step in their . . .

Read More

EMA Management Board: Highlights of October 2023 meeting

The EMA’s Management Board met on 5 October in Amsterdam. The article below covers the . . .

Read More

Welcome Mednet as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Mednet as a new . . .

Read More

Welcome Allucent as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Allucent as a . . .

Read More

Welcome KCR as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome KCR as a new . . .

Read More

Welcome Debiopharm as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Debiopharm as a . . .

Read More

HMA/EMA joint Big Data Steering Group: Big Data Workplan 2023-2025

The joint HMA-EMA Big Data Steering Group (BDSG) have released their latest workplan, . . .

Read More

ACT EU PA04 – Multi-stakeholder Workshop on ICH E6 R3

As part of the Accelerating Clinical Trials in the EU (ACT EU) multi-annual workplan . . .

Read More

European Medicine’s Agency – Reflection paper on the use of artificial intelligence in the lifecycle of medicines

The EMA has opened a public consultation on a reflection paper presenting views . . .

Read More

Welcome Instem as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Instem as a new . . .

Read More

Regulatory Considerations Expert Group reviews draft FDA Guidance

The ACDM Regulatory Considerations Expert Group have reviewed and submitted comments on . . .

Read More